Latest Fluorescence in situ hybridization Stories
Initiatives taken by the FDA to provide better personalized healthcare facilities propels the growth of the European In Situ Hybridization market
FORT WORTH, Texas, December 19, 2014 /PRNewswire/ -- The in-situ hybridization market was valued at $927.5 million in 2013 and is expected to grow at a CAGR of 11.7% from
The webinar will focus on detecting RNA and protein simultaneously by flow cytometry, December 16, 2014. Yorba Linda, CA (PRWEB) December 11, 2014 One
Company Expands IP Portfolio Covering Test Methods to Identify Chromosomal Abnormalities including 3q (TERC) and 5p (TERT) in Cervical Cells GAITHERSBURG, Md., Oct.
Combines NGS and FISH Testing for Comprehensive Cancer Profiling FT. MYERS, Fla., Oct. 16, 2014 /PRNewswire/ -- NeoGenomics, Inc.
DMG Productions explores the latest breakthroughs in biotechnology. Rockville, MD (PRWEB) October 10, 2014 CytoTest announced that they will be featured
The major application driving the global companion diagnostics market is the adoption of companion diagnostic tests in oncology for various indications and for target therapies.
NucleoLIS® is Full MIMS Purpose-built for Molecular and Cytogenetic Laboratories MILFORD, Mass., Oct.
DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular) has announced the addition of the
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.